uniQure N.V. insider Matthew C. Kapusta reported a same-day option exercise and sale of ordinary shares on July 2, 2026. The Form 4, filed July 7, shows that Kapusta exercised a stock option using transaction code **M**, acquiring **21,082 ordinary shares** at an exercise price of **$19.39 per share**. The option was already fully vested, with the filing noting that the stock option vested in full on **January 26, 2022**. Following the exercise, Kapusta’s direct holdings rose to **540,309 ordinary shares**. He then sold the same total number of shares—**21,082 ordinary shares**—in three open-market sale transactions reported under transaction code **S**. The sales were made under a prearranged trading plan adopted on **October 5, 2025**, intended to comply with **Rule 10b5-1** under the Securities Exchange Act of 1934. The first sale covered **9,200 shares** at a weighted average price of **$44.43** per share, with individual trade prices ranging from **$44.10 to $44.
Stock detail
Uniqure (QURE) stock price, chart, and key data
View Uniqure stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Uniqure
QURE · XNAS
+$7.28 (+18.06%) past day
$47.60
Overnight $47.67 (+0.15%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Operating income & Operating cash flow
Quarterly revenue, profitability, and balance-sheet snapshot
Total assets & Total liabilities
Quarterly revenue, profitability, and balance-sheet snapshot
Total equity & Shares outstanding
Quarterly revenue, profitability, and balance-sheet snapshot
Day range
$37.47 - $41.65
52-week range
$8.73 - $71.50
Close price
$39.43
Market cap
$2.7B
P/E ratio
-56
Beta
0.9
Financials
FY2026 Q1Operating income
-$47M
Operating cash flow
-$38M
EPS
—
Shares outstanding
63.1M
Total assets
$779M
Total equity
$149M
Total liabilities
$629M
About the company
UNIQURE BV
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$66.33
10
Buy
/ 11
Recent calls
06/29/2026
H.C. Wainwright
Patrick Trucchio
Buy · Price target $80.00
06/24/2026
Mizuho Securities
Uy Ear
Buy · Price target $68.00
06/22/2026
Barclays
Eliana Merle
Buy · Price target $65.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app